EMAIL THIS PAGE TO A FRIEND

Cancer research

Fibulin-5 Blocks Microenvironmental ROS in Pancreatic Cancer.


PMID 26577699

Abstract

Elevated oxidative stress is an aberration seen in many solid tumors, and exploiting this biochemical difference has the potential to enhance the efficacy of anticancer agents. Homeostasis of reactive oxygen species (ROS) is important for normal cell function, but excessive production of ROS can result in cellular toxicity, and therefore ROS levels must be balanced finely. Here, we highlight the relationship between the extracellular matrix and ROS production by reporting a novel function of the matricellular protein Fibulin-5 (Fbln5). We used genetically engineered mouse models of pancreatic ductal adenocarcinoma (PDAC) and found that mutation of the integrin-binding domain of Fbln5 led to decreased tumor growth, increased survival, and enhanced chemoresponse to standard PDAC therapies. Through mechanistic investigations, we found that improved survival was due to increased levels of oxidative stress in Fbln5-mutant tumors. Furthermore, loss of the Fbln5-integrin interaction augmented fibronectin signaling, driving integrin-induced ROS production in a 5-lipooxygenase-dependent manner. These data indicate that Fbln5 promotes PDAC progression by functioning as a molecular rheostat that modulates cell-ECM interactions to reduce ROS production, and thus tip the balance in favor of tumor cell survival and treatment-refractory disease.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

HPA005928
Anti-EMCN antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB2700787
Anti-EMCN antibody produced in rabbit, affinity isolated antibody, buffered aqueous solution
HPA000848
Anti-FBLN5 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
HPA000868
Anti-FBLN5 antibody produced in rabbit, Ab2, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500114
Anti-FBLN5 antibody produced in rabbit, affinity isolated antibody
SAB4500974
Anti-Fibronectin 1, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4502163
Anti-Mucin-14, C-Terminal antibody produced in rabbit, affinity isolated antibody
N5288
Anti-NQO1 (C-terminal) antibody produced in rabbit, ~1 mg/mL, affinity isolated antibody, buffered aqueous solution
SAB2500708
Anti-NQO1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB2501434
Anti-NQO1 antibody produced in goat, affinity isolated antibody, buffered aqueous solution
SAB1408944
Anti-NQO1 antibody produced in mouse, purified immunoglobulin, buffered aqueous solution
HPA007308
Anti-NQO1 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB1410299
Anti-NQO1 antibody produced in rabbit, purified immunoglobulin, buffered aqueous solution
47775
Menadione (K3), analytical standard
C11H8O2
SAB5300101
Monoclonal Anti-FBLN5 antibody produced in mouse, clone 3F10A5, ascites fluid
SAB5300102
Monoclonal Anti-FBLN5 antibody produced in mouse, clone 3F8D5, ascites fluid
SAB5300103
Monoclonal Anti-FBLN5 antibody produced in mouse, clone 1G6A4, ascites fluid
WH0001728M1
Monoclonal Anti-NQO1 antibody produced in mouse, clone 1E3-A6, purified immunoglobulin, buffered aqueous solution
SAB5300232
Monoclonal Anti-NQO1 antibody produced in mouse, clone 4D12, ascites fluid
SAB5300233
Monoclonal Anti-NQO1 antibody produced in mouse, clone 1A11, ascites fluid
74540
Nordihydroguaiaretic acid, ≥97.0% (HPLC)
C18H22O4
N5023
Nordihydroguaiaretic acid, ≥90% (HPLC), from Larrea divaricata (creosote bush)
C18H22O4
295647
Phosphine, electronic grade, ≥99.9995%
H3P
04004
Phosphorus, red, ≥97.0%
P
343242
Phosphorus, red, ≥99.99% trace metals basis
P
209678
Phosphorus, red, powder, 99% trace metals basis
P